Delivery Order SPE2DB22D1106-SPE2DB25FENA6
Award Date 5/12/25
Potential Completion Date 6/3/25
Potential Value $49K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $49,131.24 delivery order to AmerisourceBergen Drug Corp for the supply of JEVTANA (cabazitaxel) 60 mg/1.5 mL kits on July 22, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. JEVTANA is a chemotherapy agent used in oncology treatment, and this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,377.08 to AmerisourceBergen Drug Corp for JEVTANA 60 mg/1.5 mL kits on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. JEVTANA (cabazitaxel) is a chemotherapy medication used in cancer treatment, reflecting the pharmaceutical supply...
- The Defense Logistics Agency awarded a $16,377.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jevtana (cabazitaxel) 60 mg/1.5 ml kits. This is a non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,377.08, is for the supply of Jevtana 60 mg/1.5 ml kit, a specialty medication used in cancer treatment. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2025. AmerisourceBergen is the prime contractor, and there is no indication of any...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $37,259.45 on September 3, 2025, for the supply of Jemperli 500 mg/10 mL vials. This firm fixed-price, non-set-aside contract is scheduled for completion by September 24, 2025, with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Jemperli (venetoclax) is a targeted cancer therapy used in the treatment of hematologic malignancies, representing a specialized...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Jemperli 500 mg/10 mL vials with a ceiling value of $149,037.80 and a firm fixed price structure. This contract is a non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a substantial $1 billion vehicle valued through December 2026. The delivery order will be performed at AmerisourceBergen's...
- On August 27, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for JEMPERLI 500 mg/10 mL vials with a ceiling value of approximately $29.8K. JEMPERLI (venetoclax) is a targeted cancer therapy used in hematologic malignancies, and this order reflects the federal government's procurement of specialized pharmaceutical products to support military and veteran healthcare systems. The delivery order is structured as a firm fixed-price...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price delivery order with a ceiling value of $22,355.67 and an ultimate completion date of September 16, 2025. The contract represents a non-competitive set-aside award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.39 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Jatenzo 237 mg capsules (120 count) with a contract value of $2,276.50. This non-competitive, firm fixed-price delivery order is set to be completed by May 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply relationship with the Defense...